Latest News & Features
Europe
Unified Patent Court announces new case management system this summer | Release will be in two phases, with first phase focusing on opt-out functionalities and representatives’ registration. 12 June 2025
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/5e5d0c10-4799-11f0-a809-0b3fd081904a-Kathi%20Vidal(3).webp)
Americas
Two decisions by acting USPTO director Coke Morgan Stewart have “damaging” consequences, warns Vidal | Stewart kickstarts campaign of implied criticism of predecessor’s record. 12 June 2025
Careers
Three seasoned lawyers with experience in biotech, pharmaceutical, and medical device patent matters join the firm's practice in Washington, DC and Chicago offices. 12 June 2025
Biotechnology
Judges uphold PTAB’s finding that two Agilent patents are invalid | All claims of patents, which cover guide RNAs, found to be anticipated by prior art. 12 June 2025
Europe
Two years since the UPC opened its doors, various developments might influence the UK government to reassess its position, write Amanda Ebbutt and Paul England of Taylor Wessing. 10 June 2025
Americas
US appeals court confirms validity of Acadia's Nuplazid patents | Decision fends off generics from MSN Laboratories and Aurobindo Pharma until 2030s. 10 June 2025
Americas
Office’s acting director lifts severe penalties against patent owner following Federal Circuit remand | Issues separate decision highlighting consequences of “lengthy awareness” of patent portfolio. 10 June 2025
Americas
Biotech company convinces judges over claim construction interpretation | Alnylam “acted as lexicographer” regarding a claim term | Win comes as Moderna suffers economic challenges. 5 June 2025
Big Pharma
Companies face increasingly complex decisions over what IP to use, particularly when collaborating. Muireann Bolger hears the dos and don’ts of protection from senior counsel. 5 June 2025
Americas
With nearly four decades of patent law experience—including decades at the USPTO—new senior patent counsel joins the firm’s Washington, DC office, bringing expertise in biotech, pharma, and chemical engineering. 5 June 2025